Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PFIZER, INC.

(PFE)
  Report
Delayed Nyse  -  04:03 2022-12-02 pm EST
50.91 USD   -0.33%
12/02Pfizer bets $2.5 bln on European output boost
RE
12/02Pfizer to Spend More Than $2.5 Billion to Expand Plants in Belgium, Ireland
MT
12/02Vaxxinity's Phase 3 COVID-19 Vaccine Trial Meets Endpoints
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer, BioNTech File European Medicines Agency Application for Omicron Booster Dose for Children

09/28/2022 | 11:58am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
BIONTECH SE 0.16% 169.74 Delayed Quote.-34.16%
PFIZER, INC. -0.33% 50.91 Delayed Quote.-13.50%
All news about PFIZER, INC.
12/02Pfizer bets $2.5 bln on European output boost
RE
12/02Pfizer to Spend More Than $2.5 Billion to Expand Plants in Belgium, Ireland
MT
12/02Vaxxinity's Phase 3 COVID-19 Vaccine Trial Meets Endpoints
MT
12/02Pfizer Plans EUR1.2 Billion Investment in Belgium
MT
12/02Pfizer to invest more than $2.5 billion to expand European manufacturing
RE
12/01Transcript : Pfizer Inc. Presents at 5th Annual Evercore ISI HealthCONx Confe..
CI
12/01Strong Eurozone Manufacturing Data Pushes European Bourses to Close Mostly Higher
MT
12/01MarketScreener’s World Press Review : December 1st, ..
MS
12/01Pfizer Invites Public to Register for Webcast of Pfizer Near-Term Launches + High-Value..
BU
12/01Pfizer Aims to Double Production at Dublin Plant With 1.2 Billion-Euro Investment
MT
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2022 100 B - -
Net income 2022 33 621 M - -
Net cash 2022 5 430 M - -
P/E ratio 2022 8,96x
Yield 2022 3,17%
Capitalization 286 B 286 B -
EV / Sales 2022 2,80x
EV / Sales 2023 3,50x
Nbr of Employees 79 000
Free-Float 59,0%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 50,91 $
Average target price 53,78 $
Spread / Average Target 5,63%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
David M. Denton Chief Financial Officer & Executive Vice President
Mikael Dolsten Executive VP, President-Research & Development
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.-13.50%285 774
JOHNSON & JOHNSON4.57%467 679
ELI LILLY AND COMPANY34.07%356 089
ABBVIE INC.20.87%289 331
NOVO NORDISK A/S22.04%285 887
MERCK & CO., INC.43.58%278 995